EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Follitropin alfa versus follitropin alfa/lutropin alfa (rFSH/rLH) in progestin-primed ovarian stimulation: a prospective two-center observational cohort study

Emre Pabuccu, Yusuf Aytac Tohma, Sinan Ozkavukcu

Frontiers in Reproductive Health · 03.11.2026 · 8

DOI: 10.3389/frph.2026.1948337 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Frontiers in Reproductive Health, online erschienen am 03.11.2026. Verfasst von Emre Pabuccu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Ufuk University School of Medicine, Ankara, Türkiye. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The contribution of recombinant LH during progestin-primed ovarian stimulation (PPOS) remains uncertain. We compared recombinant FSH alone (GON) with recombinant FSH plus recombinant LH (PER) in a prospective two-center observational cohort.

Methods

The full enrolled cohort included 213 women (121 GON; 92 PER), including 11 with day-3 transfer. MII oocyte count was the primary outcome. The primary negative binomial model adjusted for female age, AMH, baseline AFC, previous failed cycles and center. Propensity scores used the same covariates; matching was 1:1, exact within center, using Mahalanobis distance within a logit propensity-score caliper. The per-protocol (PP) population comprised the 202 women whose embryos were cultured to day 5; in the full-cohort (ITT) analysis, the 11 women with day-3 transfer contributed zero day-5 blastocysts.

Results

The primary adjusted MII incidence rate ratio (IRR) for PER versus GON was 1.01 (95% CI 0.91–1.11; p = 0.910); the PP IRR was 1.00 (95% CI 0.91–1.11; p = 0.939). The number of MII oocytes was similar in both groups (median 11 in both), and this finding did not change after adjustment for baseline characteristics or after propensity-score matching. PER was associated with more day-5 blastocysts (median 4 vs. 3) and more top-quality blastocysts (median 2 vs. 1), and these differences persisted after adjustment and matching. Positive β-hCG rates after the first frozen embryo transfer were similar (47.6% vs. 43.2%). OHSS was rare (1 PER and 2 GON cases, all mild), and no cycle was canceled.

Conclusions

No statistically significant difference in MII count was detected, and equivalence was not established. The higher day-5 blastocyst counts associated with PER may reflect an effect of LH on embryo developmental competence rather than on oocyte yield; this exploratory finding does not establish a causal or clinical benefit and requires confirmation in randomized trials. https://clinicaltrials.gov/study/NCT07348757 , NCT07348757.

Schlagwörter

Stichwörter der Autor:innen

dydrogesteronehigh respondersmature oocytesprogestin-primed ovarian stimulationpropensity score matchingrecombinant FSHrecombinant LH

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Ufuk University School of Medicine, Ankara, Türkiye.
  • Centrum Clinic IVF Center, Ankara, Türkiye.
  • Bahceci IVF Center, Ankara, Türkiye.
  • Department of Obstetrics and Gynecology, Atılım University School of Medicine, Ankara, Türkiye.
  • Department of Embryology and Histology, Medipol University School of Medicine, Ankara, Türkiye.

Zitieren

APA

Pabuccu, E., Tohma, Y. A., & Ozkavukcu, S. (2026). Follitropin alfa versus follitropin alfa/lutropin alfa (rFSH/rLH) in progestin-primed ovarian stimulation: a prospective two-center observational cohort study. Frontiers in Reproductive Health, 8. https://doi.org/10.3389/frph.2026.1948337

Vancouver

Pabuccu E, Tohma YA, Ozkavukcu S. Follitropin alfa versus follitropin alfa/lutropin alfa (rFSH/rLH) in progestin-primed ovarian stimulation: a prospective two-center observational cohort study. Frontiers in Reproductive Health. 2026;8. doi:10.3389/frph.2026.1948337

BibTeX
@article{Pabuccu2026,
  author = {Pabuccu, Emre and Tohma, Yusuf Aytac and Ozkavukcu, Sinan},
  title = {Follitropin alfa versus follitropin alfa/lutropin alfa (rFSH/rLH) in progestin-primed ovarian stimulation: a prospective two-center observational cohort study},
  journal = {Frontiers in Reproductive Health},
  year = {2026},
  volume = {8},
  doi = {10.3389/frph.2026.1948337}
}
Kostenlos starten →